Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3

Watchlist Manager
Oncoclinicas do Brasil Servicos Medicos SA Logo
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
Watchlist
Price: 7.07 BRL 10.47% Market Closed
Updated: May 20, 2024
ONCO3
/
Income Statement
/
Revenue

Oncoclinicas do Brasil Servicos Medicos SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oncoclinicas do Brasil Servicos Medicos SA
Revenue Peer Comparison

Comparables:
FLRY3
AALR3
D
DASA3

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
Revenue
R$5.5B
CAGR 3-Years
39%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Fleury SA
BOVESPA:FLRY3
Revenue
R$6.5B
CAGR 3-Years
30%
CAGR 5-Years
19%
CAGR 10-Years
15%
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
Revenue
R$1.2B
CAGR 3-Years
8%
CAGR 5-Years
2%
CAGR 10-Years
N/A
D
Diagnosticos da America SA
BOVESPA:DASA3
Revenue
R$14.3B
CAGR 3-Years
27%
CAGR 5-Years
29%
CAGR 10-Years
19%

See Also

What is Oncoclinicas do Brasil Servicos Medicos SA's Revenue?
Revenue
5.5B BRL

Based on the financial report for Dec 31, 2023, Oncoclinicas do Brasil Servicos Medicos SA's Revenue amounts to 5.5B BRL.

What is Oncoclinicas do Brasil Servicos Medicos SA's Revenue growth rate?
Revenue CAGR 5Y
39%

Over the last year, the Revenue growth was 34%. The average annual Revenue growth rates for Oncoclinicas do Brasil Servicos Medicos SA have been 39% over the past three years , 39% over the past five years .

ALPHA SPREAD
Join more than 138,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.